An Integrative Analysis of the Putative Gefitinib-resistance Related Genes in a Lung Cancer Cell Line Model System

E-ISSN： 1873-5576|15|5|423-434

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.15, Iss.5, 2015-01, pp. : 423-434

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Gefitinib in Non-Small-Cell Lung Cancer

By Frampton James E. Easthope Stephanie E.

American Journal of PharmacoGenomics, Vol. 5, Iss. 2, 2005-01 ,pp. : 133-136

Adis International

Access to resources Recommend Favorite

Gefitinib in non-small cell lung cancer

By Tamura Kenji Fukuoka Masahiro

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 6, 2005-06 ,pp. : 985-993

Informa Healthcare

Access to resources Recommend Favorite

Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations

By Park In Kim Jin Jung Jae Han Ji-Youn

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 791-799

Springer Publishing Company

Access to resources Recommend Favorite

Interstitial lung disease in gefitinib-treated Japanese patients with non-small-cell lung cancer: genome-wide analysis of genetic data

By Nyberg Fredrik Barratt Bryan J Mushiroda Taisei Takahashi Atsushi Jawaid Ansar Hada Shuji Umemura Takaaki Fukuoka Masahiro Nakata Koichiro Ohe Yuichiro Kato Harubumi Kudoh Shoji March Ruth Nakamura Yusuke Kamatani Naoyuki

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 965-975

Future Medicine

Access to resources Recommend Favorite

The role of gefitinib in the management of Asian patients with non-small cell lung cancer

By Chang Alex Y

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. : 401-411

Informa Healthcare

Access to resources Recommend Favorite